Found 601 results
Victor JD, Rizvi SM, Conte MM.  2019.  Image segmentation driven by elements of form.. Vision Res. 159:21-34.
Gauthier S.  2019.  Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS.. Neurology. 93(1):46.
Doria JW, Forgacs PB.  2019.  Incidence, Implications, and Management of Seizures Following Ischemic and Hemorrhagic Stroke.. Curr Neurol Neurosci Rep. 19(7):37.
Isaacson RS, Hristov H, Saif N, Hackett K, Hendrix S, Melendez J, Safdieh J, Fink M, Thambisetty M, Sadek G et al..  2019.  Individualized clinical management of patients at risk for Alzheimer's dementia.. Alzheimers Dement. 15(12):1588-1602.
Seligman L, Kovanlikaya I, Pisapia DJ, Naeger DM, Magge R, Fine HA, Chiang GC.  2019.  Integrated PET-MRI for Glioma Surveillance: Perfusion-Metabolism Discordance Rate and Association With Molecular Profiling.. AJR Am J Roentgenol. 212(4):883-891.
Leasure AC, Qureshi AI, Murthy SB, Kamel H, Goldstein JN, Walsh KB, Woo D, Shi F-D, Huttner HB, Ziai WC et al..  2019.  Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage.. Stroke. 50(8):2016-2022.
Dinkin M, Lavi E, Winterkorn J, Oliveira C, Merkler AE.  2019.  Ischemic Optic Neuropathy Secondary to Intravascular Lymphoma.. J Neuroophthalmol. 39(3):313-318.
Andersen BM, Miranda C, Hatzoglou V, DeAngelis LM, Miller AM.  2019.  Leptomeningeal metastases in glioma: The Memorial Sloan Kettering Cancer Center experience.. Neurology. 92(21):e2483-e2491.
Daileda T, Vahidy FS, Chen PRoc, Kamel H, Liang CW, Savitz SI, Sheth SA.  2019.  Long-term retreatment rates of cerebral aneurysms in a population-level cohort.. J Neurointerv Surg. 11(4):367-372.
Roh DJ, Albers DJ, Magid-Bernstein J, Doyle K, Hod E, Eisenberger A, Murthy S, Witsch J, Park S, Agarwal S et al..  2019.  Low hemoglobin and hematoma expansion after intracerebral hemorrhage.. Neurology. 93(4):e372-e380.
Weaver J, Sarva H, Barone D, Bobker S, Bushara K, Hiller A, Ishii M, Jankovic J, Lakhani S, Niotis K et al..  2019.  McLeod syndrome: Five new pedigrees with novel mutations.. Parkinsonism Relat Disord. 64:293-299.
Linkous A, Balamatsias D, Snuderl M, Edwards L, Miyaguchi K, Milner T, Reich B, Cohen-Gould L, Storaska A, Nakayama Y et al..  2019.  Modeling Patient-Derived Glioblastoma with Cerebral Organoids.. Cell Rep. 26(12):3203-3211.e5.
Luo L, Andrews H, Alcalay RN, Poyraz FCarvalho, Boehme AK, Goldman JG, Xie T, Tuite P, Henchcliffe C, Hogarth P et al..  2019.  Motor phenotype classification in moderate to advanced PD in BioFIND study.. Parkinsonism Relat Disord. 65:178-183.
Zhang S, Chiang GChia-Yi, Magge RS, Fine HAlan, Ramakrishna R, Chang EWang, Pulisetty T, Wang Y, Zhu W, Kovanlikaya I.  2019.  MRI based texture analysis to classify low grade gliomas into astrocytoma and 1p/19q codeleted oligodendroglioma.. Magn Reson Imaging. 57:254-258.
Ivanidze J, Lum M, Pisapia D, Magge R, Ramakrishna R, Kovanlikaya I, Fine HA, Chiang GC.  2019.  MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma.. J Neuroimaging. 29(3):357-363.
Omran SSalehi, Chatterjee A, Chen ML, Lerario MP, Merkler AE, Kamel H.  2019.  National Trends in Hospitalizations for Stroke Associated With Infective Endocarditis and Opioid Use Between 1993 and 2015.. Stroke. 50(3):577-582.
Sandrone S, Berthaud JV, Chuquilin M, Cios J, Ghosh P, Gottlieb-Smith RJ, Kushlaf H, Mantri S, Masangkay N, Menkes DL et al..  2019.  Neurologic and neuroscience education: Mitigating neurophobia to mentor health care providers.. Neurology. 92(4):174-179.
Reshef ER, Schiff ND, Brown EN.  2019.  A Neurologic Examination for Anesthesiologists: Assessing Arousal Level during Induction, Maintenance, and Emergence.. Anesthesiology. 130(3):462-471.
Victor JD, Boie SD, Connor EG, Crimaldi JP, G Ermentrout B, Nagel KI.  2019.  Olfactory Navigation and the Receptor Nonlinearity.. J Neurosci. 39(19):3713-3727.
VanderPluym JH, Hamilton K, Hindiyeh NA, Robbins MS, Starling AJ, Vargas BB, Gibbons SK, Vgontzas A.  2019.  Online Migraine Education and Support for Patients: Perspectives from the American Headache Society Emerging Leaders Program.. Headache. 59(9):1656-1658.
Michel M, Beck D, Block N, Blumenfeld H, Brown R, Carmel D, Carrasco M, Chirimuuta M, Chun M, Cleeremans A et al..  2019.  Opportunities and challenges for a maturing science of consciousness.. Nat Hum Behav. 3(2):104-107.
Perumal J, Fox RJ, Balabanov R, Balcer LJ, Galetta S, Makh S, Santra S, Hotermans C, Lee L.  2019.  Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE.. BMC Neurol. 19(1):116.
Julie DAR, Ahmed Z, Karceski SC, Pannullo SC, Schwartz TH, Parashar B, A Wernicke G.  2019.  An overview of anti-epileptic therapy management of patients with malignant tumors of the brain undergoing radiation therapy.. Seizure. 70:30-37.
Lin M-H, Kamel H, Singer DE, Wu Y-L, Lee M, Ovbiagele B.  2019.  Perioperative/Postoperative Atrial Fibrillation and Risk of Subsequent Stroke and/or Mortality.. Stroke. 50(6):1364-1371.
Cabrera LY, Sarva H, Sidiropoulos C.  2019.  Perspectives on the Earlier Use of Deep Brain Stimulation for Parkinson Disease from a Qualitative Study of U.S. Clinicians.. World Neurosurg. 128:e16-e20.